Effect of Dacarbazine Chemotherapy in Well-Differentiated Neuroendocrine Tumors

被引：0
|
作者：
Mueller, D. [1 ]
Rinke, A. [1 ]
Gress, T. [1 ]
机构：
[1] Univ Marburg, Dept Internal Med, Div Gastroenterol & Endocrinol, D-3550 Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine tumor; chemotherapy; dacarbazine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Cetinkaya, Raziye Boyar
    Vatn, Morten
    Aabakken, Lars
    Bergestuen, Deidi S.
    Thiis-Evensen, Espen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 734 - 741
  • [32] Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors
    Shunsuke Tsukamoto
    Shin Fujita
    Tomohiro Yamaguchi
    Seiichiro Yamamoto
    Takayuki Akasu
    Yoshihiro Moriya
    Hirokazu Taniguchi
    Tadakazu Shimoda
    International Journal of Colorectal Disease, 2008, 23 : 1109 - 1113
  • [33] Sarcopenia in Patients with Advanced Gastrointestinal Well-Differentiated Neuroendocrine Tumors
    Romano, Elena
    Polici, Michela
    Marasco, Matteo
    Lerose, Francesco
    Dell'Unto, Elisabetta
    Nardacci, Stefano
    Zerunian, Marta
    Iannicelli, Elsa
    Rinzivillo, Maria
    Laghi, Andrea
    Annibale, Bruno
    Panzuto, Francesco
    Caruso, Damiano
    NUTRIENTS, 2024, 16 (14)
  • [34] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Reidy, Diane L.
    Tang, Laura H.
    Saltz, Leonard B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03): : 143 - 152
  • [35] Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
    Roeland F. de Wilde
    Barish H. Edil
    Ralph H. Hruban
    Anirban Maitra
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 199 - 208
  • [36] Clinical and Pathological Behavior of Well-Differentiated Pancreatic Neuroendocrine Tumors
    Perez-Casanova, Luis
    Serrano, Teresa
    Navas, Carlos
    Salazar, Ramon
    Villabona, Carlos
    Valls, Carles
    Fabregat, Juan
    Condom, Enric
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142
  • [37] Molecular profiling of well-differentiated neuroendocrine tumors: Role of ctDNA
    Lamarca, A.
    Frizziero, M.
    Barriuso, J.
    Kapacee, Z. A.
    Mansoor, W.
    McNamara, M.
    Hubner, R.
    Valle, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 30 - 30
  • [38] An unexpected effect of chronic treatment with Temozolomide in patients with metastatic, well-differentiated neuroendocrine tumors
    Laffi, A.
    Nicosia, L.
    Spada, F.
    Rubino, M.
    Fazio, N.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 138 - 138
  • [39] Oxaliplatin based chemotherapy for advanced well-differentiated neuroendocrine tumors: A systematic review and meta-analysis
    Wang, Jian
    Wang, Xiangling
    Chu, Yunxia
    Li, Shuguang
    Hao, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, Alex J.
    Ueberroth, Benjamin E.
    McGarrah, Patrick W.
    Buckner Petty, Skye A.
    Kendi, Ayse Tuba
    Starr, Jason
    Hobday, Timothy J.
    Halfdanarson, Thorvardur R.
    Sonbol, Mohamad Bassam
    ONCOLOGIST, 2021, 26 (05): : 383 - 388
12345